Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06186297
Other study ID # 30017882
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date June 30, 2023

Study information

Verified date December 2023
Source Concordia University, Montreal
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cranberry is a fruit native to North America that is widely grown in Quebec and has been shown to have the highest antioxidant capacity among the most commonly eaten fruits. Consequently, consuming cranberries prior to exercising may help to improve exercise endurance by preventing accumulation of reactive oxygen species. For aerobic endurance, in order to maintain a certain pace for a long duration, runners need to effectively neutralize reactive oxygen species. Although it is not the only component involved in running, offsetting reactive oxygen species should improve running performance. To test this, we plan to investigate the effects, both acute and chronic, of a cranberry extract on the oxygen consumption in 18-35 year old males and females. The present research project will contribute to expand our knowledge of how cranberry extract can exert a positive effect, and thus improve aerobic performance or even every day life. This project can benefit a wide range of the population, from sedentary individuals and older adults to elite athletes by providing an all-natural supplement alternative.


Description:

Each participant will be involved in the study for a period of 5 weeks, during which they will commit to 3 visits: The first visit (on week 1) will be to obtain baseline measurements. During the second visit (on week 2), acute effects of the cranberry extract will be evaluated by giving a single high dose to the participants 1 hour before the trial events. The third visit (on week 5) will be to evaluate the chronic effects of the cranberry extract after 4 weeks of daily consumption. We will use the following instruments to gather data: - Questionnaires (height, weight, dietary patterns, to determine training level, past injuries, single or multisport athlete etc.) - Continuous wavelength NIRS will be used to measure oxygen levels in the quadriceps using portable Moxy monitors. For this test the subjects will be wearing the portable and convenient oxygen monitors taped firmly on the appropriate muscles. NIRS is a non-invasive method and measures the level of oxygenation in the muscle tissues by sending near-infrared light through the skin, which travels through the muscle fibers and is then recovered and returned to the surface of the skin and into the back of the sensor. As light moves through the skin layers (skin, fat and muscle), it scatters, and it identifies the oxygenated and the deoxygenated blood cells due to their colors. The blood cells identified are hemoglobin and myoglobin cells. For the actual test, the quadriceps will be activated using electrical twitch stimulation at either 4 or 6Hz for 30 s at a current level that produce vigorous but submaximal contractions. During the contraction, the NIRS will be used in combination with short duration ischemic cuff periods (200 mmHg) applied by a Hokanson rapid cuff inflator. By repeating 5 second occlusion followed by 5 second deflation 6 times, at the same time as we activate the muscle, we will be able to determine muscle metabolism (mitochondrial oxygen consumption) by using the rate constant of the recovery from high to low metabolic rate. • Skinfold measurement of the placement area for the Moxy oxygen monitors to determine if the light can penetrate subcutaneous tissues (has to be <15mm)


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - recreationally active, healthy and between the ages of 18-35. Exclusion Criteria: - smoker; use of ergogenic substances or any kind or drugs that could alter the cardiovascular responses; resting BP higher than 140/90 mm Hg; and cardiovascular or metabolic disease (especially hypertension and diabetes)

Study Design


Intervention

Dietary Supplement:
Cranberry extract
polyphenol PAC-1

Locations

Country Name City State
Canada Concordia University Montréal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Concordia University, Montreal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen consumption 20 minutes
Secondary Blood flow 20 minutes
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05011591 - Swimming Economy in Swimmers and Paraswimmers as a Function of SR(Stroke Rate) and V(Velocity) Manipulations (NePTUNE-3) N/A
Recruiting NCT05912595 - EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2) N/A
Completed NCT04209647 - A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults N/A
Completed NCT01327820 - Study of Post-operative Oxygen Consumption Following Vascular Surgery N/A
Active, not recruiting NCT03874923 - Comparison of 250 ml Versus 500 ml of Fluid Challenge N/A
Recruiting NCT05381779 - Comparison the Effects of Inspiratory Muscle Training and Aerobic Exercise Training in Patients With Post COVID-19 N/A
Completed NCT02802111 - Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults N/A
Enrolling by invitation NCT05608603 - Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
Not yet recruiting NCT06018038 - Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer
Enrolling by invitation NCT05499871 - Effect of a Gait Retraining Intervention and a Minimalist Footwear Transition on Foot-ankle Strength, Running Economy and Injury in Endurance Runners. N/A
Completed NCT03602365 - Gentle Jogger and Oxygen Consumption N/A
Completed NCT02774577 - Oxygen Consumption After Acute Whole Body Vibration Session N/A
Recruiting NCT06072755 - Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry
Recruiting NCT06391424 - Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU)
Recruiting NCT04482556 - Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max) Encore Device in Mechanically Ventilated Children N/A
Recruiting NCT05511584 - Oxygen Consumption and Sevoflurane Uptake Based on Physiological Dead Space Estimation N/A
Recruiting NCT05379608 - Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. N/A
Completed NCT06113133 - Assessment of Maximal Oxygen Uptake in Cardiac Rehabilitation
Completed NCT05090254 - The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion N/A
Completed NCT05798130 - Assessment of Oxygen Extraction Rate Changes Following Red Blood Cell Transfusion in the Intensive Care Unit